Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 2/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.48 |
| ▸ | CYP1A1 | P04798 | 2/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.48 |
| ▸ | CYP2E1 | P05181 | 2/20 | 0.48 |
| ▸ | CYP2C8 | P10632 | 2/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.48 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.48 |
| ▸ | CYP4B1 | P13584 | 2/20 | 0.48 |
| ▸ | CYP2B6 | P20813 | 2/20 | 0.48 |
| ▸ | CYP3A5 | P20815 | 2/20 | 0.48 |
| ▸ | CYP2A7 | P20853 | 2/20 | 0.48 |
| ▸ | CYP3A7 | P24462 | 2/20 | 0.48 |
| ▸ | CYP2F1 | P24903 | 2/20 | 0.48 |
| ▸ | CYP2C18 | P33260 | 2/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.48 |
| ▸ | CYP2J2 | P51589 | 2/20 | 0.48 |
| ▸ | CYP4F2 | P78329 | 2/20 | 0.48 |
| ▸ | CYP4F8 | P98187 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12326180 | 0.82 | CA1 (0.50) | ACHECYP3A4CYP1A1CYP1A2CYP2E1 | |
| SCHEMBL12989512 | 0.80 | MAPK1 (0.48) | ACHECYP3A4CYP1A1CYP1A2CYP2E1 | |
| SCHEMBL12989388 | 0.78 | CYP11B1 (0.52) | CYP3A4CYP1A2CYP2D6CYP2A6CYP2C9 | |
| SCHEMBL25251070 | 0.76 | LMNA (0.46) | CYP3A4CYP1A2CYP2A6CYP2C19MEN1 | |
| SCHEMBL28492019 | 0.76 | GPR3 (0.46) | ACHECYP3A4CYP1A1CYP1A2CYP2E1 | |
| SCHEMBL1673424 | 0.76 | ALDH1A1 (0.46) | CYP3A4CYP1A1CYP1A2CYP2E1CYP2C8 | |
| SCHEMBL17178230 | 0.76 | CYP1A2 (0.48) | ACHECYP3A4CYP1A1CYP1A2CYP2E1 | |
| SCHEMBL7699015 | 0.75 | MAPT (0.46) | CYP3A4CYP1A2CYP2D6CYP2A6CYP2C9 | |
| SCHEMBL30159166 | 0.74 | ABL1 (0.56) | ACHECYP3A4CYP1A1CYP1A2CYP2E1 | |
| SCHEMBL21114228 | 0.73 | MAPK1 (0.46) | ACHECYP3A4CYP1A1CYP1A2CYP2E1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150316863-A1 | ELECTROPHOTOGRAPHIC PHOTOSENSITIVE MEMBER, PROCESS CARTRIDGE AND ELECTROPHOTOGRAPHIC APPARATUS, AND GALLIUM PHTHALOCYANINE CRYSTAL | CANON KABUSHIKI KAISHA (JP) | 2015-11-05 | — | — | US | disclosed |
| US-20150316863-A1 | ELECTROPHOTOGRAPHIC PHOTOSENSITIVE MEMBER, PROCESS CARTRIDGE AND ELECTROPHOTOGRAPHIC APPARATUS, AND GALLIUM PHTHALOCYANINE CRYSTAL | CANON KABUSHIKI KAISHA (JP) | 2015-11-05 | — | — | US | disclosed |
| US-5149819-A | Squarylium compounds and optical information recording medium using the same | RICOH COMPANY, LTD. (JP) | 1992-09-22 | — | — | US | disclosed |
| US-5085909-A | SQUARYLIUM COMPOUNDS AND OPTICAL INFORMATION RECORDING MEDIUM USING THE SAME | RICOH COMPANY, LTD. (JP) | 1992-02-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150316863-A1 | ELECTROPHOTOGRAPHIC PHOTOSENSITIVE MEMBER, PROCESS CARTRIDGE AND ELECTROPHOTOGRAPHIC APPARATUS, AND GALLIUM PHTHALOCYANINE CRYSTAL | GGCT, GRK7, GNG2 | ACHE 3059/4885CYP3A4 2097/4885CYP1A1 2229/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.